TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation

Dominik Wieland(University of Freiburg), Janine Kemming(University of Freiburg), Anita Schuch(University of Freiburg), Florian Emmerich(University Medical Center Freiburg), Percy A. Knolle(TUM Klinikum), Christoph Neumann‐Haefelin(University of Freiburg), Werner Held(Ludwig Cancer Research), Dietmar Zehn(Weihenstephan-Triesdorf University of Applied Sciences), Maike Hofmann(University of Freiburg), Robert Thimme(University of Freiburg)
Nature Communications
May 3, 2017
Cited by 205Open Access
Full Text

Abstract

Abstract Differentiation and fate of virus-specific CD8 + T cells after cessation of chronic antigen stimulation is unclear. Here we show that a TCF1 + CD127 + PD1 + hepatitis C virus (HCV)-specific CD8 + T-cell subset exists in chronically infected patients with phenotypic features of T-cell exhaustion and memory, both before and after treatment with direct acting antiviral (DAA) agents. This subset is maintained during, and for a long duration after, HCV elimination. After antigen re-challenge the less differentiated TCF1 + CD127 + PD1 + population expands, which is accompanied by emergence of terminally exhausted TCF1-CD127-PD1 hi HCV-specific CD8 + T cells. These results suggest the TCF1 + CD127 + PD1 + HCV-specific CD8 + T-cell subset has memory-like characteristics, including antigen-independent survival and recall proliferation. We thus provide evidence for the establishment of memory-like virus-specific CD8 + T cells in a clinically relevant setting of chronic viral infection and we uncover their fate after cessation of chronic antigen stimulation, implicating a potential strategy for antiviral immunotherapy.


Related Papers

No related papers found

Powered by citation graph analysis